pharmacie et médicaments – Vente imminente de Biogaran

This written question concerns the imminent sale of Biogaran, a major pharmaceutical company. It seeks information on the implications of this sale for the French pharmaceutical sector and public health. The question highlights potential impacts on medicine availability, pricing, and competition within France. It aims to understand the regulatory oversight and potential consequences for consumers and the healthcare system.